Arthritis Flashcards
Symptomatic relief for RA
Paracetamol
NSAID
Opiods
Non selective NSAIDs
Ibuprofen
Indomethacin
Naproxen
COX-2 selective NSAID
Celecoxib
Name DMARDS for RA
Methotrexate
Chloroquine
Sulfasalazine
How long for DMARDs to show effect
6 weeks to 6 months
Max intra-articular steroid injections per year
4
MOA od methotrexate
Methotrexate and its active polyglutamate metabolites inhibit the activity of key enzymes such as dihydrofolate reductase, adenosine ribonucleotide transformylase, and thymidylate synthetase:
interferes with several intracellular metabolic processes, in particular:
- one-carbon metabolism
- de novopurine synthesis and
- de novo pyrimidine synthesis
This antimetabolic effect may lead to alteration in intracellular nucleotide pools and increased adenosine release, determining the anti-rheumatic effect of methotrexate
CIs for methotrexate
- Pre-existing blood dyscrasias
- Existing renal or hepatic disease
- Previous or existing herpes/varicella infections
- Serous effusions
- Pregnancy or lactation
AEs of Methotrexate
Bone marrow suppression
Mucosal ulceration
Hepatotoxicity
Dermatological (Alopecia, Skin rashes, Pigmentations, Urticaria)
Nephropathy
Hyperuricaemia
Other (Headaches, drowsiness, malaise, fatigue, blurred vision)
What must be given with methotrexate
Folic acid
Interactions with methotrexate
NSAIDs (decreased clearance)
Phenytoin, cotrimoxazole, trimethoprim (additive antifolate activity)